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Abstract
Significance: Re-excision rates for women with invasive breast cancer undergoing breast con-
serving surgery (or lumpectomy) have decreased in the past decade but remain substantial. This
is mainly due to the inability to assess the entire surface of an excised lumpectomy specimen
efficiently and accurately during surgery.
Aim: The goal of this study was to develop a deep-ultraviolet scanning fluorescence microscope
(DUV-FSM) that can be used to accurately and rapidly detect cancer cells on the surface of
excised breast tissue.
Approach: A DUV-FSM was used to image the surfaces of 47 (31 malignant and 16 normal/
benign) fresh breast tissue samples stained in propidium iodide and eosin Y solutions. A set of
fluorescence images were obtained from each sample using low magnification (4×) and fully
automated scanning. The images were stitched to form a color image. Three nonmedical
evaluators were trained to interpret and assess the fluorescence images. Nuclear–cytoplasm ratio
(N/C) was calculated and used for tissue classification.
Results: DUV-FSM images a breast sample with subcellular resolution at a speed of
1.0 min ∕cm2. Fluorescence images show excellent visual contrast in color, tissue texture, cell
density, and shape between invasive carcinomas and their normal counterparts. Visual interpre-
tation of fluorescence images by nonmedical evaluators was able to distinguish invasive carci-
noma from normal samples with high sensitivity (97.62%) and specificity (92.86%). Using N/C
alone was able to differentiate patch-level invasive carcinoma from normal breast tissues with
reasonable sensitivity (81.5%) and specificity (78.5%).
Conclusions: DUV-FSM achieved a good balance between imaging speed and spatial resolution
with excellent contrast, which allows either visual or quantitative detection of invasive cancer
cells on the surfaces of a breast surgical specimen.
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1 Introduction
Breast cancer afflicts millions of women in the United States and worldwide, of whom about a
half to two-thirds will undergo breast conserving surgery (BCS) or lumpectomy.1,2 The goal of
BCS is to completely remove the tumor with a narrow rim/margin of normal, unaffected breast
tissue while preserving as much normal tissue as possible. Although outcomes have improved
over the last decade, women with positive margins (cancer cells at the surface of the surgical
specimen) still have at least a twofold increased risk of cancer recurrence,3–5 and thus, are often
recommended to undergo additional surgery to achieve clear margins. Additional surgery is
associated with additional discomfort, surgical complications, worse cosmesis, and additional
emotional stress, time, and financial burdens to patients and their caregivers.6,7 The current re-
excision rate of BCS in the United States is 14% to 18% and highly variable among surgeons,
ranging from 0% to 92%.2,8–12 One reason why women with positive margins need to undergo re-
excision surgery is that definitive pathologic margin status is typically not available until several
days after surgery.
Currently, there are several different methods for intraoperative margin assessment that vary
markedly in performance among studies. Radiologic examination of the resected specimen with
two-dimensional (2D) mammography is largely available and rapid. However, it has low sensi-
tivity and variable accuracy compared to other techniques and does not improve re-excision
rates.13,14 Pilot studies evaluating intraoperative specimen radiograph using digital breast tomo-
synthesis may be promising (sensitivity 77% to 93% and specificity 78% to 98%), but it requires
further investigation.15,16 Frozen section analysis is an involved pathological technique that typ-
ically samples only a portion of the surgical margin, performs poorly on fatty breast tissue, and has
variable false-negative rates.17 In addition, this technique is extremely labor- and time-intensive,
costly, requires on-site or telepathology, and significantly lengthens operating room (O.R.) time
(20 to 30 min).13 Cytologic imprint prep analysis by touch preparation or scrape preparation is less
labor-intensive (about 13 min); however, this technique requires a specialized cytopathologist.18
A considerable number of patients undergo BCS at an ambulatory surgery center where there is no
pathologist or cytopathologist available. For these reasons, intraoperative pathology options are
not routinely available or adopted.13,19 Lastly, the only Federal Drug Administration (FDA)-
approved device for margin analysis, the MarginProbe, is a pen-like probe that utilizes radio-
frequency spectroscopy to analyze tumor margins. Limitations include low sensitivity (67% to
75.2%) and specificity (46.4% to 60%) and reliance on user-guided spot scanning.20,21
Margins of resected lumpectomy specimens have recently been assessed using a number of
emerging technologies, including optical coherence tomography (OCT),22–25 diffuse reflectance
spectroscopy (DRS),26–28 DRS and fluorescence spectroscopy,29 Raman spectroscopy,30 photo-
acoustic tomography (PAT),31–33 fluorescence or polarization imaging,34,35 spatial frequency
domain imaging (SFDI) or structured illumination imaging,36,37 bioimpedance spectroscopy
(ClearEdge),38 mass spectrometry (i-Knife),39 and light-sheet microscopy,40,41 among others.
A detailed review of these emerging techniques can be found in three recent comprehensive
reviews.12,42,43 While each of these studies has shown promising results, none of the emerging
imaging technologies has demonstrated the capability of analyzing an entire lumpectomy speci-
men (six margins) with both adequate resolution and time efficiency required in a clinical setting.
Microscopy with UV surface excitation (MUSE) is a nondestructive technology that can
image fresh, unfixed tissue that is stained with multiple fluorescence dyes, thus generating fluo-
rescence images with microscopic resolution, sharpness, and contrast.44 Yoshitake et al.45 found
that the histological features of breast tissue images obtained with a high incident angle water
immersion illumination MUSE system have limited correspondence with those obtained with
conventional hematoxylin and eosin (H&E) histology and suggested that further development is
needed for breast surgical applications. Xie et al. developed a MUSE system with a fully auto-
mated three-dimensional (3D) sample translation that can image fresh tissue at a rate of
5 min ∕cm2, and an algorithm that can create a fluorescent analog of conventional H&E images.
They further demonstrated that MUSE could provide microscopic visualization of breast margin
surfaces at speeds relevant for intraoperative use.46
In this study, we investigated the translational potential of MUSE as an intraoperative tool
for margin assessment during BCS. Specifically, we aimed to determine the features of MUSE
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images that can be used to distinguish fresh, unprocessed malignant from normal/benign breast
tissues, the accuracy of the technology, and the speed at which a breast tissue sample can be
surveyed. In order to obtain both adequate accuracy and time efficiency required in a clinical
setting for margin assessment, we chose a combination of deep ultraviolet (DUV) (285 nm)
excitation and low magnification (4×) with slightly reduced spatial resolution (2 to 3 μm) to
achieve a faster imaging speed. High speed is necessary to survey all six margins of a lumpec-
tomy specimen (an average size of 20 cm2) during surgery without causing significant O.R.
delays.28 We purposefully focused on detecting invasive cancer cells on sample surfaces based
on the 2014 Society of Surgical Oncology (SSO) and American Society for Radiation Oncology
(ASTRO) Guidelines that support “no tumor cells at the inked margin” are adequate for women
with stage I/II invasive cancers who undergo BCS followed by whole-breast radiation.47 We
demonstrate that: (1) a low-cost deep-ultraviolet fluorescence scanning microscope (DUV-
FSM) can rapidly image fresh breast tissues with excellent contrast at a resolution sufficient
to resolve cells of different tissue types; (2) visual interpretation of MUSE images can achieve
excellent sensitivity and specificity in distinguishing invasive cancer from normal breast tissue;
and (3) nuclear–cytoplasm ratio (N/C) may also be used for quantitative assessment to differ-
entiate cancer from normal breast tissue. These translational potentials of MUSE technology
have not been explored in previous studies.
2 Methods
2.1 Imaging System
We have converted an inverted microscope to a DUV-FSM to image the surfaces of fresh tis-
sues from breast surgical specimens. A schematic of the DUV-FSM system is shown in Fig. 1.
Fig. 1 The DUV-FSM margin imaging system: (a) principle schematic of the system and (b) the
simplified imaging light path. A 45-mW, 285-nm LED with a short-pass filter and a fused silica ball
lens has been added to the inverted fluorescence microscope for fluorescence excitation.
Fluorescence emission is collected by a Plan Fluor 4× (numerical aperture ¼ 0.13) objective.
The excitation/emission filter block of the microscope is switched to the empty position. Large
specimen mosaic scanning is achieved by a motorized XY stage.
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A 285–nm LED (M285L4, Thorlabs, Newton, New Jersey) is mounted on the right side of an
inverted fluorescence microscope (EXI-310, Accu-scope, Commack, New York) for oblique
back-illumination. A 325-nm short-pass filter (XUV0325, Asahi Spectra, Torrance, California)
is placed in front of the LED to block emission spectrum tails in the visible range, avoiding
possible overlap with fluorescence signals. A fused silica ball lens (model #67-388, Edmund
Optics, Barrington, New Jersey) is used as a condenser to converge the LED radiation for a
smaller illumination field and improved power density. The LED, short pass filter, and ball lens
are mounted inside a lens tube. A 3D-printed arm holds the lens tube and is mounted on an
optical post to allow for easy adjustment of the LED height and illumination angle so that the
illumination area is slightly larger than the field-of-view (FOV) of the microscope objective.
The power density of the LED light at the tissue surface was measured at 9.4 mW/cm2. Once
the position of the LED was optimized, the entire system was fixed on an optical breadboard.
To image a lumpectomy specimen, the specimen is placed on one of its six margins in a 70-mm-
diameter quartz dish (1.0-mm thick) to minimize autofluorescence of the glass. The quartz dish
is mounted on a robotic, stepper-motor controlled XY stage custom designed for fast mosaic
imaging (ABĒMIS LLC, Cleveland, Ohio). The excitation/emission filter block of the micro-
scope is switched to the empty position so that the fluorescent signals of multiple fluorophores
can be captured by a color camera without having to switch emission filters during the imaging
process. A cooled, USB3.0 camera (MTR3CCD06000KPA, Hangzhou ToupTek Photonics Co.,
Ltd, Hangzhou, China) was selected for its large image sensor and pixel size, very low dark
noise, and high image transfer speed, which are very important for fast image acquisition in
intraoperative margin assessment. The camera has 2748 × 2200 pixels, a pixel size of 4.54 μm,
and active area of 14.6 × 12.8 mm2. A 4× apochromatic long working distance objective lens
with a numerical aperture of 0.13 was selected as a compromise between good lateral resolution
(2 to 3 μm) and a large effective imaging area of 3.48 × 2.78 mm2. The FOVof the objective lens
is slightly larger than the imaging area of the camera to avoid distortions at the edge of the FOV.
The microscope is housed inside a dark enclosure to prevent personnel exposure to DUV light
and to eliminate background from room light.
2.2 Breast Tissue Sample Preparation
Forty-seven fresh human breast tissues obtained from lumpectomy and mastectomy specimens
were acquired from the Medical College of Wisconsin (MCW) Tissue Bank. Information about
the tissue subtype, number of samples, and surface area are provided in Table 1. Specimens were
grossly examined and procured by Tissue Bank staff (MP) then placed in phosphate-buffered
saline (PBS) solution, transported on ice to the research lab immediately, and stored in a refrig-
erator. Samples were imaged on the day of excision. Propidium iodide (PI, P21493, Thermo
Fisher Scientific, Waltham, Massachusetts) was used for nuclear staining and eosin Y (EY,
230251-25G, Sigma-Aldrich, St. Louis, Missouri) for staining of cytoplasm and connective tis-
sues. Both PI and EY can be effectively excited at 285 nm. PI has a fluorescence emission in the
yellow-red spectral range and EY has an emission in the green-yellow spectral range. For stain-
ing, PI and EY were dissolved in PBS (pH 7.2) to a concentration of 100 μg∕ml and 1.0 mg∕ml,
respectively. Each specimen was stained in PI solution for 1 min, then in EY solution for 20 s,
and finally rinsed in PBS for 10 s. Once staining was completed, the specimen was placed onto










Invasive ductal carcinoma (IDC) 25 0.45 to 5.5 (1.2) 3 to 48 (15) 445
Invasive lobular carcinoma (ILC) 6 0.91 to 3.9 (2.35) 4 to 55 (15.5) 133
Adipose-rich normal 3 3.9 to 5.29 (4.84) 48 to 70 (58) 176
Fibrous/glandular-rich normal 13 2.4–9 (4.41) 36–141 (91) 1135
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the quartz plate of the specimen holder. Awide pallet knife was used to gently flatten the tissue
against the quartz plate to remove air bubbles between the tissue and plate. Once the tissue was
in the correct position, excess liquid was removed from the edges using a Kimwipe. Although
both sides of the samples were imaged, the samples were thin and the two surfaces were similar.
Thus, only images from one side were included in data analysis. All handling and safety guide-
lines for biohazards were carefully followed. The study was exempt from the Institutional
Review Board and Institutional Biosafety Committee reviews.
2.3 Imaging Protocol
The specimen holder loaded with a tissue specimen was immobilized on the motorized XY stage
after a specimen size measurement by a caliper. The focal plane was set at the bottom surface of
the specimen. Mosaic images were collected with conservative overlapping regions of 0.75 mm
in the X direction and 0.60 mm in the Y direction for a tradeoff between speed and stitching
accuracy. The number of scanning steps is decided by the specimen size, effective imaging area,
and the dimension of overlapping. The temperature of the camera was set to −18°C to reduce the
electronic noise level. All images of each specimen were captured with a constant exposure time
ranging from 50 to 100 ms, depending on the sample tissue type. The image acquisition and
motor movements were controlled by a customized software developed in Microsoft Visual
C#.NET. Image files were saved in TIFF format with 2748 × 2200 pixels. After imaging, the
raw images were transformed to hue–saturation–lightness (HSV) color space images. The open
source image processing package Fiji48 was used to process the tissue images. A Fiji plugin
named BaSiC49 was applied to the saturation and lightness channels to correct for background
and shadings caused by uneven and tilted illumination of a single DUV LED. The color space
transform is necessary to preserve the original color information during illumination correction.
After transforming back to red-green-blue (RGB) color space, image stitching was performed
using a Fiji plugin developed by Preibisch et al.50 Finally, histogram equalization was applied to
the R and G color channels of the stitched image to enhance the visual contrast.
2.4 Histopathology Evaluation
Routine histopathology was used for final diagnosis of tissue samples. Fereidouni et al.44
previously shown that PI and EY staining does not interfere with subsequent histopathology
processes. Following DUV-FSM imaging, tissue specimens were returned to MCW Tissue Bank
for formalin-fixed paraffin-embedded (FFPE) tissue processing. In order to obtain full face sec-
tions for histologic evaluation, an average cut depth of ∼200 μm into the embedded tissue block
was used during microtomy. Tissue sections were transferred to glass slides and stained with
H&E. All slides were digitalized by a Panoramic 250 Flash II slide scanner (3DHistech Ltd.,
Budapest, Hungary). An unblinded qualitative side by side comparison of H&E and MUSE
images was performed by an experienced breast pathologist (JMJ).
2.5 Visual Inspection of MUSE Images
Visual inspection of MUSE images was performed by three nonmedical evaluators to assess the
accuracy of nonpathologists to differentiate cancer from noncancer tissue. The 47 breast tissue
samples were divided into two groups: training and test groups. The training group included
three invasive carcinomas (two IDC and one ILC) and two normal tissues (one fibrotic and
one adipose-rich breast sample), while the test set included 5 ILC, 23 IDC, 2 adipose-rich,
and 12 fibrotic/nonadipose-rich normal samples. Three nonmedical evaluators (TGS, DHY, and
AE) who were blinded to the pathological diagnosis were trained by the pathologist (JMJ) and
imaging engineer (TL) during a 1-h session to visually identify the diagnostically useful fea-
tures (such as adipose, ducts, cell density, infiltration, etc.) in the training MUSE images using
the associated H&E images. After training, each evaluator was provided MUSE images of sam-
ples in the test group without access to correlative H&E images. The evaluators interpreted
MUSE images and provided a diagnosis (invasive carcinoma versus normal) for each of the
test samples.
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2.6 Quantitative Image Analysis
Quantitative analysis was applied to DUV tissue images to extract diagnostically useful param-
eters that may be useful for detecting positive tumor margins of lumpectomy specimens during
BCS. Previous studies have shown that breast cancer cells have irregular cell size and shape,
enlarged nuclei, and increased N/C.51,52 In this study, we investigated the feasibility of using N/C
as a biomarker to differentiate invasive carcinoma from normal breast parenchyma at the surface
of the tissue samples. Tumor region(s) on the stitched MUSE image was outlined based on the
corresponding H&E image. Since PI-stained cell nuclei primarily emit lights in the yellow-red
wavelength range, only the red channel (R-channel) of the stitched images in RGB color space
was extracted and used to calculate the N/C.
The process for N/C calculation is shown in Fig. 2. First, the R-channel image (not shown)
was extracted from the color MUSE image (a) and (e). Segmentation of the R-channel image was
implemented by combining edge detection and intensity thresholding.53 The edge detection
Sobel operator with adaptive threshold detects the edge information, while intensity thresholding
eliminates textures caused by other features. The intensity threshold was set to 70% of the 1%
brightest pixels in the image, based on our experience. The segmented binary images (b) and (f)
were divided into a set of small patches of 250 × 250 μm2 (or 198 × 198 pixels) in size, and
N/C was calculated for each small patchs (c) and (g) by dividing the number of white pixels by
the total number of pixels within the patch. Then, N/Cs of neighboring 8 × 8 small patches were
averaged and merged to form a large patch of 2 × 2 mm2 in size, which resulted in an N/C ratio
map with 2 × 2 large patches (d) and (h). Awindow size of 2 × 2 mm2 was selected to match the
spatial resolution of standard breast pathology, which samples at a step of 2 mm. Larger patches
were used to reduce the sensitivity to small features with high cell density, such as lobules, ducts,
and blood vessels. In general, larger patch size results in lower spatial resolution and sensitivity
for cancer cell detection, but also a lower false positive rate. To minimize the effect of tissue
patches at the boundaries, large patches with more than half (or 32) small patches that have no
cells (i.e., N∕C ¼ 0) were excluded in further analysis.
Fig. 2 Demonstration of N/C calculation process with (a)–(d) an IDC and (e)–(h) a normal sample.
(a) and (e) A 4 × 4 mm2 area from the fluorescence images of an IDC and a normal sample,
respectively. (b) and (f) The binary image after nuclei segmentation from the same region as
in (a and e). (c) and (g) The calculated N/C map of small patches (250 × 250 μm2), with color
bar on right signifying N/C values. (d) and (h) N/C of large patches (2 × 2 mm2) obtained by aver-
aging over 8 × 8 small patches from (c) and (g). As seen in color bars on right of N/C maps, low N/C
ratios are represented by blue shades; higher N/C ratios are depicted by green, yellow, orange and
red shades.
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The large patches were manually classified into adipose-rich and nonadipose-rich normal,
ILC and IDC in accordance with H&E images. The number of large patches per tissue sample
and total number of patches for each tissue subtype are presented in Table 1. This resulted in a
total of 1889 large patches of N/C images, including 445 patches from 25 IDC, 133 patches
from 6 ILC, 176 patches from 3 adipose-rich, and 1135 patches from 13 nonadipose-rich nor-
mal tissues. All patches were used for the following comparison and classification studies.
Mean N/C was compared between the four tissue subtypes (IDC, ILC, adipose-rich, and non-
adipose-rich normal) and between invasive (IDC, ILC) and normal using generalized estimat-
ing equations (GEE) to account for repeated observations per sample. Tukey’s adjustment was
used for multiple pairwise comparisons.54 For classifications, receiver operating characteristic
(ROC) curves were constructed using patch-level N/C to predict invasive versus normal tissue,
IDC versus ILC among invasive samples, and adipose-rich versus nonadipose-rich tissue
among normal samples. The Youden Index, which weighs false positive and false negative
errors equally, was used to determine the cutoff point for the calculation of patch-level sensi-
tivity and specificity in differentiating invasive and normal tissue. The analysis was done using
SAS 9.4 (SAS Institute, Cary, North Carolina).
3 Results
3.1 Breast Tissue Images
The study resulted in stitched MUSE images and FFPE H&E images obtained from 47 breast
specimens. The average imaging speed was 1.0 min ∕cm2. DUV fluorescence and H&E images
of one sample from each tissue type are presented below. Figures 3(a) and 3(b) show fluores-
cence and H&E images of a nonadipose-rich sample of benign breast glands with interspersed
fibroadipose tissue stroma. Most of the sample is loose connective breast tissue with low nuclear
density and appears light green. Tubular-shaped structures, e.g., blood vessels [Fig. 3(c)], ducts
[Fig. 3(e)], and lobules [Figs. 3(d) and 3(f)], are easily identifiable. The two-layers of epithelia of
the ductal-lobular system have higher nuclear densities than blood vessels. Terminal duct lobular
units exhibit high nuclear density and their shapes are more complicated than ducts and blood
vessels. In addition, lobules have clustered foci of dense nuclei comprising glands while ducts
tend to have a solitary structure.
Fluorescence and H&E images of a grade one ILC with multiple foci of ductal carcinoma in
situ (DCIS) and surrounding adipose tissue are shown in Fig. 4. ILC cells in the middle (enclosed
by the dashed lines) appear in pink and yellow in the DUV fluorescence image [Fig. 4(a)] and
can be easily distinguished from the adipocytes at the left and the right sides, which appear as
individual or clusters of rounded small droplets in dark green with hyposcattered bright pink
nuclei. Tumor regions exhibit infiltrating single cells characteristic of ILC in both the H&E and
MUSE images. Four areas of DCIS were identified in the H&E image [Fig. 4(b)], three of which
(indicated by yellow arrows 1 to 3) were on the surface and appeared to be dark or have loss of
fluorescence. The shallow penetration depth (∼20 μm45) of DUV lights makes DCIS below the
surface invisible, such as the one indicated by arrow 4 in the H&E image. A biopsy site (black
box) shows higher brightness in yellow with lighter background color. The benign adenosis
region in the red box also has a high nuclear density but lacks single file infiltrating patterns
seen in tumor regions. Air bubbles also appeared in the fluorescence image, but careful specimen
handling and flattening can alleviate or avoid such artifacts.
Fluorescence and H&E images of a grade 2 IDC surrounded by adipose tissue are shown in
Figs. 5(a) and 5(b). Adipocytes on the left, right, and upper sides appear darker in green than the
epithelial and connective tissues. Like the ILC specimen above, IDC cells inside the dashed line
appear in pink and yellow and can be easily distinguished from the adipocytes in dark green and
epithelial and connective tissues in light green in Fig. 5(a). Of note, the right side of the tumor,
such as the area highlighted by the red box, shows tumor infiltration into the neighboring adipose
tissue, better visualized at higher power, as shown in Fig. 5(c). Particularly, the tumor area high-
lighted by the blue box has very high nuclear density and is at the interface between fibrotic
stroma and adipose tissue, which correlates well with the corresponding H&E image. In
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comparison, the area on the right side of the dashed line, representing normal adipose tissue, as
highlighted in the white box shown in Fig. 5(d), has much lower nuclear density. A portion of the
upper side of the specimen was compressed during imaging and shows clear folds. A thorough
check before imaging can avoid this issue.
The fluorescence and H&E images of a high-grade IDC specimen with necrosis and sur-
rounding adipose tissue are shown in Figs. 6(a) and 6(b), respectively. Again, adipose tissue
on the left side appears dark green and the tumor region inside the dashed line has high nuclear
density and poorly differentiated cells. Foci of necrosis are observed from the fluorescence
image and corresponding positions on the H&E images which show weaker (pink) nuclear stain-
ing and loss of cellular detail. The upper left corner of the MUSE image in Fig. 6(a) includes
some pink areas with high cell density, but no cancer cells are identified in the corresponding
H&E image in Fig. 6(b). Because the H&E image was obtained from a tissue slide below the
sample surface, there is not enough information to determine whether there were some cancer
cells on the surface of the specimen used for fluorescence images.
3.2 Performance of Visual Interpretation of MUSE Images
Results from visual interpretation of the MUSE images of the 42 tissue samples in the test
group by the three evaluators are summarized in Table 2. Evaluator A identified all cancer
Fig. 3 Normal human breast tissue. (a) The fluorescence image of a nonadipose-rich sample
(21 × 21 mm2) of benign breast glands with loose connective tissues in light green and inter-
spersed fibroadipose tissue stroma in dark green, with the specimen photo in the white box and
(b) corresponding FFPE H&E image. Zoomed fluorescence and H&E images of: (c) muscular-
walled blood vessel is indicated by the red arrow, (d) small lobule indicated by the yellow arrow,
(e) duct indicated by the blue arrow, and (f) lobule with mild adenosis and dilated glands indicated
by the black arrow.
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samples correctly, while evaluators B and C each missed one (false negative rates of 3.6%).
Evaluators A and evaluator B identified all normal samples correctly, but evaluators C interpreted
three normal samples as cancer. Overall, the three evaluators achieved an average sensitivity and
specificity of 97.62% and 92.86%, respectively, and an accuracy of 96.03%. Evaluators spent ∼1
to 2 min to review the MUSE image of a test sample before making a diagnosis.
Fig. 5 Human breast tissues with IDC. (a) The fluorescence image of an IDC sample
(25 × 18 mm2) with three sides surrounded by adipose tissues. The specimen photo is presented
in the white box. (b) The FFPE H&E image of the same sample. The tumor region is enclosed
within the dashed lines. Benign ducts are indicated by red, yellow, and black arrows from different
sites. White arrow indicates the blood vessel. High nuclear density at the interface between fibrotic
stroma and adipose tissue is highlighted by the blue box. The areas highlighted by the red and
white boxes are shown in (c) and (d), respectively.
Fig. 4 Human breast tissue with ILC and DCIS. (a) The fluorescence image of an ILC sample
(20 × 10 mm2) with adjacent adipose tissue at the two ends. A specimen photo is included in the
upper right corner. (b) FFPE H&E image of the same sample. ILC cells enclosed by the dashed
lines appear pink and yellow in the DUV fluorescence image and can be easily distinguished from
the adipocytes at the left and the right sides, which appear as individual or clusters of rounded
small droplets in dark green with hypo-scattered bright pink nuclei. DCIS sites are pointed by
arrows 1, 2, 3, respectively. The DCIS indicated by arrow 4 is not visible in the fluorescence image,
likely because it is slightly below the surface. Biopsy site is highlighted by the black box. A biopsy
site usually forecasts abnormalities within the site or nearby. Benign adenosis is highlighted by the
red box.
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3.3 Quantitative Analysis by N/C Values
The 1889 large patches of N/C images from the 47 breast tissue samples were manually clas-
sified into adipose-rich, nonadipose-rich normal, ILC and IDC tissues in accordance with the
H&E images. Figure 7 shows the calculated N/C values from the MUSE and H&E images for
seven representative tissue samples. The N/C values extracted from the MUSE images are all
higher (MUSE∕H & E ¼ 1.36 ∼ 3.0) than those extracted from the H&E images, which may be
attributed to the larger sectioning depth (∼20 μm) of the DUV light than the thickness of a
paraffin section (4 to 5 μm) and the lower magnification (4×) used by the DUV-FSM system
compare to the 40× magnification used for routine H&E images. In general, the higher the cell
density of the tissue sample, the lower the MUSE/H&E ratio. Most importantly, the MUSE
Table 2 Results of visual diagnosis of the 42 breast samples in the test group.
Evaluator A Evaluator B Evaluator C
AverageCancer Normal Cancer Normal Cancer Normal
Path cancer 28 0 27 1 27 1
Path normal 0 14 0 14 3 11
Sensitivity 100% 96.43% 96.43% 97.62%
Specificity 100% 100% 78.57% 92.86%
Accuracy 100% 97.62% 90.48% 96.03%
Fig. 6 IDC sample with necrosis. (a) The fluorescence image of a high-grade IDC sample
(25 × 17 mm2) with necrosis and the specimen photo in the white box. (b) FFPE H&E image
of the same sample. The tumor region is enclosed within the dashed lines and the region in the
green box exhibits necrosis.
Fig. 7 Comparison of N/C values extracted from MUSE and H&E images of representative tissue
types.
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images retain the contrast between invasive and normal/benign breast samples, and in both meth-
ods, lobular tissues are harder to separate from low and medium density IDC and ILC samples.
Boxplot of N/C per sample of the four tissue types is presented in Fig. 8(a). The calculated
mean patch-level N/C value was 0.0280 0.0098 for adipose-rich (n ¼ 176), 0.0706 0.0059
for nonadipose-rich normal tissues (n ¼ 1135), 0.2013 0.0150 for IDC (n ¼ 445), and
0.2307 0.0456 for ILC (n ¼ 133). The GEE model determined that there was a significant
difference (p < 0.001) among the four tissue subtypes except between ILC and IDC (p ¼
0.54). Figure 8(b) shows boxplots of two-class comparison, showing N/C of invasive carcinoma
(IDC and ILC) to be significantly different (n < 0.0001) from normal tissues. In the ROC curve
in Fig. 8(c), the area under the curve was 0.8631 and, whenN∕C ¼ 0.093982was used as thresh-
old, the patch-level sensitivity, and specificity in differentiating invasive carcinoma from normal
tissues were 81.5% and 78.5%, respectively.
4 Discussion
This study investigated the feasibility of using DUV fluorescence scanning microscopy as a
potential intraoperative tool to detect positive margins of freshly excised breast tumor specimen
during BCS. Propidium iodide and eosin Y have been used to stain the tissues for enhanced
fluorescence contrast between invasive and normal/benign breast tissues. Our MUSE images
show excellent visual contrast in color, tissue texture, cell density, and shape between ILC, IDC,
and DCIS and normal tissues. Nonexpert evaluators with minimal training were able to distin-
guish IDC and ILC accurately and quickly from normal breast tissues by simple visual inter-
pretation of MUSE images. As the majority of breast cancer surgery is performed in settings
where a pathologist is generally not readily available, we chose nonmedical staff to evaluate the
MUSE images to demonstrate that visual evaluation of the MUSE images is simple, fast, and
accurate, and does not require significant training or expertise. Therefore, the DUV-FSM should
be practical and generalizable to most settings as it does not require specialized resources or
training. In addition to providing surgeons high contrast images for visual inspection, N/C from
Fig. 8 Results of statistical comparison and classification. (a) The boxplot of N/C by specimen
subtype (adipose-rich, nonadipose-rich normal, IDC, and ILC). Each color in each tissue type
includes all patches from that sample. N represents the number of samples and n is the total
number of patches from those samples. (b) The boxplot of two-class classification. Outliers are
represented by red crosses in (b). (c) ROC curve for classifying patch-level normal and invasive
tissue. J is the Youden’s index.
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MUSE images showed significant difference [Fig. 8(b)] between invasive carcinoma and normal
breast tissues. Reasonable patch-level sensitivity and specificity in differentiating invasive
carcinoma from normal was achieved using a trained statistical classification model and N/C
as a single discriminator. N/C has not been extensively used as a parameter for intraoperative
assessment of breast margins.
DUV-FSM has several important features. First, DUV-FSM can image large margins of var-
iable size with subcellular resolution. Since the size of lumpectomy margins varies and most
positive margins typically involve small microscopic foci of cancer,55 a device with both large
margin coverage and microscopic resolution is highly desirable to rapidly evaluate lumpectomy
margin status intraoperatively with both low false-negative and false-positive rates. However,
many technologies currently under investigation are either a point device (e.g., optical spectros-
copy, i-Knife, and MarginProbe) or a high-resolution device with very small field of view
(e.g., OCT and confocal) that requires excessive time to manually scan a surgical margin or
a wide-field imaging device with very low spatial resolution (e.g., fluorescence imaging and
SFDI). Compared to near-infrared light and visible light, using DUV light to detect tumor at
the surface should result in subcellular spatial resolution (2 to 3 μm) even with a low magni-
fication objective (e.g., 4×), which is sufficient in resolving cellular structures and cell nuclei in
ex vivo breast tissue, and much lower background noise caused by fluorescence emission from
deeper cells and tissue scattering. With automated scanning and stitching, lumpectomy margins
of different size can be easily surveyed by varying the number of 4× images in the X and Y
directions in the user interface of the DUV-FSM software. Hence, the DUV-FSM has a high
imaging speed at a spatial resolution that is adequate to achieve a high accuracy for detection
of a small amount of cancer cells. This feature is clinically critical because it allows tumor
margins of a wide range dimensions to be imaged rapidly during BCS.
The DUV-FSM system described here, like other MUSE devices,44–46 directly images fresh
specimens without the need for complex intraoperative radiography and/or pathology process-
ing. This method is extremely simple, easy to use, relatively low in cost, and does not require
radiology, pathology, or cytology expertise, thereby making it attractive to community hospitals
and surgery centers where most BCS procedures are performed. Using DUV-FSM for intra-
operative margin imaging is nondestructive to the specimen and does not negatively impact
postoperative pathology, which remains the gold standard for margin assessment. The sensitivity
and specificity for rapid visual inspection of MUSE images were high, even among nonexpert
evaluators with minimal training, and thus should not pose significant barriers to surgeon adop-
tion or operating room workflow as most surgeons already interpret specimen radiograph results.
To our knowledge, this study is the first to report the sensitivity and specificity of MUSE tech-
nology for detection of cancer versus noncancerous breast tissue.
Previous MUSE studies focused on creating H&E mimicking images by color mapping for
histopathological assessment, which requires a pathologist to interpret the images. While creat-
ing H&E mimicking images from MUSE images is necessary to understand if MUSE can
provide the same or equivalent diagnostically useful information as one can get from routine
pathological analysis, it is also important to investigate how this technology may be used in
the intraoperative clinical setting assessing lumpectomy margin status where large and variable
margin coverage, high speed, and simplicity are key factors. This DUV-FSM study emphasizes
the importance of providing surgeons diagnostically interpretable information about margin sta-
tus within minutes. We aim to generate high contrast images that allow a surgeon to visually
diagnose or a computer algorithm (e.g., statistical or machine learning model) to determine if a
margin is positive and re-excision is necessary to achieve a negative margin during the primary
surgery. Equally important is determining if margins are negative to prevent the unnecessary
removal of additional breast tissue. Best efforts are focused on achieving a balance between
high resolution to obtain more cellular and subcellular details about the tissue surface and fast
scan speed that allows specimen processing, imaging, and interpretation of all six margins of a
lumpectomy specimen in the O.R. Speed is critical for intraoperative margin assessment as every
minute in the operating room costs around at least $36.56 The tradeoff between resolution and
speed is necessary until a practical margin tool that can achieve both high resolution and high
speed is developed. Using a low 4×magnification objective with an FOVover 4 mm in diameter,
simultaneous excitation of two fluorescence dyes with distinct emission color (PI and EY), and a
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universal serial bus (USB) 3.0 color camera to detect the fluorescence signals significantly
reduces the scan time for a large specimen to 1 cm2∕min. The DUV-FSM method requires
80 s for sample staining and ∼1 min for image processing. In contrast, the Xie system requires
5 min for staining, 5 min to scan a 1.0 cm2 margin, and 5 min for image processing to create
fluorescent analog of H&E staining.46
This study has some limitations. First, this study purposefully focused on invasive cancer so
pure DCIS samples were not included in the study. We are aware that SSO/ASTRO released
consensus guidelines on margins in 2016 for BCS with whole breast radiation in the setting
of DCIS (with or without microinvasive component), which accounts for about 25% of all breast
cancers. The recommendation is to achieve a 2-mm margin to minimize the risk of tumor recur-
rence in the same breast and emphasizes the importance of clinical judgment in determining
selective re-excision for patients with negative margins <2 mm.57 We acknowledge that
DUV-FSM, as well as other MUSE devices, will not be able to assess margins to 2 mm and
close margin status (tumor cells present within 2 mm of the surface but not at the surface) will
need to be determined on final routine pathological assessment. However, our preliminary work
demonstrates the possibility of using DUV-FSM to detect positive margins for DCIS (see Fig. 4),
which should translate into decreased re-excision rates in positive-margin cases. Recent data
from two large studies showed that women with DCIS who underwent BCS and post-lumpec-
tomy whole breast radiation treatment with a close margin did not have a higher rate of local
recurrence compared to those with a wider margin width.58,59 Clasier et al.40 also concluded that
a 2-mm margin may not be necessary if comprehensive surface imaging is achieved. Therefore,
the clinical priority to intraoperatively detect close but negative margins for pure DCIS cases
may decrease in the future.
Second, it was challenging to obtain accurate coregistration between DUVand corresponding
H&E images. While DUV fluorescence images were taken from the top 20 μm of samples due to
the shallow penetration depth of DUV light, routine H&E slide cutting techniques produces
H&E images up to 200 μm into the FFPE tissue block. The optical sectioning thickness of
∼20 μm is also thicker than a typical paraffin-embedded thickness of ∼4 μm, which can cause
subtle differences between DUVand H&E images. For instance, tubular-shape structures such as
ducts and blood vessels usually have optically clear lumina in H&E images, but this is not the
case in fluorescence images (Fig. 3). In Figs. 4(a) and 4(b), one focus of DCIS appears in the
H&E image but is not easily identifiable in the fluorescence image. In Fig. 5(a), a topology of
tissue compression and surface folding, which may be minimum is in whole lumpectomy spec-
imens, is visible in the fluorescence image but was not observed in the H&E images.
Ideally, the segmentation algorithm accurately identifies all nuclei in the background, but this
is difficult to achieve with simple edge detection and intensity thresholding because of the com-
plicated textures and nuclei stacking. Fluorescence signals from cells slightly below the speci-
men surface can cause blurring and reduced intensity in nuclei images due to scattering, thus
contributing to error in N/C calculation. A more advanced nuclei segmentation algorithm is
needed for more accurate identification of cell nuclei in future studies. Some images showed
a few small out of focus areas due to the irregular surface of fresh sliced tissue samples. Using
the 4× objective lens plus tissue flattening significantly reduced blurring and thus minimized its
impact on the accuracy of the device, particularly when visual evaluation was used. Acquiring
image stacks for depth of field correction is an excellent way to obtain clear images.46 However,
this approach may not be clinically practical because it takes at least five times longer for image
acquisition and processing. The DUV-FSM device has the capability of autofocusing and we will
investigate the autofocusing option in our future studies. Benign structures such as adenosis,
blood vessels, and ducts may also include regions with higher N/C. Given the small size of
the vessels and ducts, N/C of these tissue types can be averaged down using a large patch size.
In this study, 2 × 2 mm2 patch size was selected for the calculation of N/C to be compatible with
standard histopathology, which samplings at a step of 2 mm. An optimal image patch size may be
determined by comparing the ROC curves obtained at different patches with more samples.
The 285-nm LED is capable of exciting PI and EY at the same time. PI stains cell nuclei,
which is the primary contrast for detection of invasive samples in this study. EY stains connective
tissue and cytoplasm. While EY staining is not very useful in the N/C method, it allows visu-
alization of tissue structures beyond cell nuclei (otherwise would be dark), which is very useful
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in the visual evaluation method and potentially in a machine learning algorithm. We did notice
the EY pooling effects and will explore ways to mitigate this effect in our future studies. Finally,
the number of breast samples that have been imaged is relatively small. More samples are needed
to calculate sensitivity and specificity for detection of invasive cancer more accurately. It also
takes the current DUV-FSM about 1 min to image a 1-cm2 breast specimen. Improvements in the
motorized XY stage and scanning algorithm coupled with faster image transfer rate should
reduce the scan time by a factor of at least 10.
5 Conclusions
In conclusion, a standard inverted microscope has been converted to a DUV-FSM as a potentially
promising intraoperative tool for fast imaging of breast margins during BCS. Preliminary fluo-
rescence images show excellent visual contrast in color, tissue texture, cell density, and shape
between ILC, IDC, and normal breast tissues. Visual examination of MUSE images with min-
imal training achieved excellent accuracy in detecting invasive carcinoma from normal tissues.
Statistical analysis identified significant differences in N/C between cancerous and normal tissue
and achieved reasonably good sensitivity and specificity. While further work is needed to
optimize DUV-FSM, future studies are also needed to explore the potential of DUV-FSM for
intraoperative lumpectomy margin assessment.
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